CD86 and acute myeloid leukemia: The B7-positive group was predominant (60%) and was mostly characterized by the presence of molecules with known or most probably inhibitory role in cancer and AML in particular (B7.2, PD-L1, PD-L2, B7-H3, B7-H4) (28, 44).